Frequent mutation of the p53 gene in human esophageal cancer
- PMID: 2263646
- PMCID: PMC55293
- DOI: 10.1073/pnas.87.24.9958
Frequent mutation of the p53 gene in human esophageal cancer
Abstract
Sequence alterations in the p53 gene have been detected in human tumors of the brain, breast, lung, and colon, and it has been proposed that p53 mutations spanning a major portion of the coding region inactivate the tumor suppressor function of this gene. To our knowledge, neither transforming mutations in oncogenes nor mutations in tumor suppressor genes have been reported in human esophageal tumors. We examined four human esophageal carcinoma cell lines and 14 human esophageal squamous cell carcinomas by polymerase chain reaction amplification and direct sequencing for the presence of p53 mutations in exons 5, 6, 7, 8, and 9. Two cell lines and five of the tumor specimens contained a mutated allele (one frameshift and six missense mutations). All missense mutations detected occurred at G.C base pairs in codons at or adjacent to mutations previously reported in other cancers. The identification of aberrant p53 gene alleles in one-third of the tumors we tested suggests that mutations at this locus are common genetic events in the pathogenesis of squamous cell carcinomas of the esophagus.
Similar articles
-
p53 mutational spectrum of esophageal carcinomas from five different geographical locales in China.Cancer Epidemiol Biomarkers Prev. 1996 Apr;5(4):277-84. Cancer Epidemiol Biomarkers Prev. 1996. PMID: 8722219
-
p53 gene mutations in Barrett's epithelium and esophageal cancer.Cancer Res. 1991 Aug 15;51(16):4495-9. Cancer Res. 1991. PMID: 1868473
-
p53 tumor suppressor gene mutation in early esophageal precancerous lesions and carcinoma among high-risk populations in Henan, China.Cancer Res. 1994 Aug 15;54(16):4342-6. Cancer Res. 1994. PMID: 8044781
-
p53 mutations in human cancers.Science. 1991 Jul 5;253(5015):49-53. doi: 10.1126/science.1905840. Science. 1991. PMID: 1905840 Review.
-
TP53 tumor suppressor gene: a model for investigating human mutagenesis.Genes Chromosomes Cancer. 1992 Jan;4(1):1-15. doi: 10.1002/gcc.2870040102. Genes Chromosomes Cancer. 1992. PMID: 1377002 Review.
Cited by
-
p53 gene mutations in esophageal cancer detected by polymerase chain reaction single-strand conformation polymorphism analysis.Jpn J Cancer Res. 1992 Jun;83(6):559-62. doi: 10.1111/j.1349-7006.1992.tb00125.x. Jpn J Cancer Res. 1992. PMID: 1644659 Free PMC article.
-
Study of p53 gene alteration as a biomarker to evaluate the malignant risk of Lugol-unstained lesion with non-dysplasia in the oesophagus.Br J Cancer. 2007 Feb 12;96(3):492-8. doi: 10.1038/sj.bjc.6603582. Br J Cancer. 2007. PMID: 17285122 Free PMC article.
-
Phase I/II adenoviral p53 gene therapy for chemoradiation resistant advanced esophageal squamous cell carcinoma.Cancer Sci. 2006 Jun;97(6):554-61. doi: 10.1111/j.1349-7006.2006.00206.x. Cancer Sci. 2006. PMID: 16734736 Free PMC article. Clinical Trial.
-
Inactivation of the p53 gene is not required for tumorigenesis of medullary thyroid carcinoma or pheochromocytoma.Jpn J Cancer Res. 1992 Nov;83(11):1113-6. doi: 10.1111/j.1349-7006.1992.tb02730.x. Jpn J Cancer Res. 1992. PMID: 1483923 Free PMC article.
-
From molecular classification to targeted therapeutics: the changing face of systemic therapy in metastatic gastroesophageal cancer.Gastroenterol Res Pract. 2015;2015:896560. doi: 10.1155/2015/896560. Epub 2015 Feb 17. Gastroenterol Res Pract. 2015. PMID: 25784931 Free PMC article. Review.
References
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
Molecular Biology Databases
Research Materials
Miscellaneous